Lipocine (LPCN) Receivables - Other (2016 - 2025)
Lipocine's Receivables - Other history spans 11 years, with the latest figure at $115272.0 for Q3 2025.
- For Q3 2025, Receivables - Other rose 26.01% year-over-year to $115272.0; the TTM value through Sep 2025 reached $115272.0, up 26.01%, while the annual FY2024 figure was $120447.0, 130.5% up from the prior year.
- Receivables - Other reached $115272.0 in Q3 2025 per LPCN's latest filing, down from $121732.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $579428.0 in Q3 2022 to a low of $24230.0 in Q2 2023.
- Average Receivables - Other over 5 years is $164447.4, with a median of $120094.0 recorded in 2022.
- Peak YoY movement for Receivables - Other: surged 63136.06% in 2021, then tumbled 92.91% in 2023.
- A 5-year view of Receivables - Other shows it stood at $247253.0 in 2021, then plummeted by 67.47% to $80427.0 in 2022, then crashed by 35.03% to $52254.0 in 2023, then skyrocketed by 130.5% to $120447.0 in 2024, then decreased by 4.3% to $115272.0 in 2025.
- Per Business Quant, the three most recent readings for LPCN's Receivables - Other are $115272.0 (Q3 2025), $121732.0 (Q2 2025), and $179027.0 (Q1 2025).